cd20 positive human nhl cell lines Search Results


rituxumab rituxan antibody  (Genentech inc)
90
Genentech inc rituxumab rituxan antibody
Therapeutic and Immune Checkpoint Blocker Monoclonal Antibodies Approved for Cancer Treatment 5 , 10 , 53
Rituxumab Rituxan Antibody, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd20+positive+human+nhl+cell+lines/rituximab+antibody/pmc05481296-31-0-2
Average 90 stars, based on 1 article reviews
rituxumab rituxan antibody - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
obinutuzumab  (Genentech inc)
90
Genentech inc obinutuzumab
Table 2. Therapeutic antibodies in Phase 2/3 or Phase 3 clinical studies of cancer indications
Obinutuzumab, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd20+positive+human+nhl+cell+lines/obinutuzumab/pmc03564874-22-4-0
Average 90 stars, based on 1 article reviews
obinutuzumab - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
rituxan  (Genentech inc)
90
Genentech inc rituxan
Table 2. Therapeutic antibodies in Phase 2/3 or Phase 3 clinical studies of cancer indications
Rituxan, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd20+positive+human+nhl+cell+lines/rituxan/10__1038_slash_scibx__2008__493-49-0-4
Average 90 stars, based on 1 article reviews
rituxan - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
pro13192199 i humanized igg1 (ocrelizumab) with modified fc increased fc riiia binding and adcc  (Genentech inc)
90
Genentech inc pro13192199 i humanized igg1 (ocrelizumab) with modified fc increased fc riiia binding and adcc
Table 2. Therapeutic antibodies in Phase 2/3 or Phase 3 clinical studies of cancer indications
Pro13192199 I Humanized Igg1 (Ocrelizumab) With Modified Fc Increased Fc Riiia Binding And Adcc, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd20+positive+human+nhl+cell+lines/humanized+anti+vegf+igg1+antibody/pm21209380-97-116-117
Average 90 stars, based on 1 article reviews
pro13192199 i humanized igg1 (ocrelizumab) with modified fc increased fc riiia binding and adcc - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
anti-cd20 monoclonal antibody therapeutics rituxan® (rituximab)  (Genentech inc)
90
Genentech inc anti-cd20 monoclonal antibody therapeutics rituxan® (rituximab)
Table 2. Therapeutic antibodies in Phase 2/3 or Phase 3 clinical studies of cancer indications
Anti Cd20 Monoclonal Antibody Therapeutics Rituxan® (Rituximab), supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd20+positive+human+nhl+cell+lines/anti+cd20+antibody/us07531628-5-3-11
Average 90 stars, based on 1 article reviews
anti-cd20 monoclonal antibody therapeutics rituxan® (rituximab) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
rhumab v114 pro131921 antibody  (Genentech inc)
90
Genentech inc rhumab v114 pro131921 antibody
Table 2. Therapeutic antibodies in Phase 2/3 or Phase 3 clinical studies of cancer indications
Rhumab V114 Pro131921 Antibody, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd20+positive+human+nhl+cell+lines/peptide+v114+/pmc03564883-225-0-3
Average 90 stars, based on 1 article reviews
rhumab v114 pro131921 antibody - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
plamotamab  (Xencor Inc)
86
Xencor Inc plamotamab
Table 2. Therapeutic antibodies in Phase 2/3 or Phase 3 clinical studies of cancer indications
Plamotamab, supplied by Xencor Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd20+positive+human+nhl+cell+lines/plamotamab/pmc12653845-41-0-2
Average 86 stars, based on 1 article reviews
plamotamab - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
t cell nk cell engagers  (Novartis)
86
Novartis t cell nk cell engagers
Table 2. Therapeutic antibodies in Phase 2/3 or Phase 3 clinical studies of cancer indications
T Cell Nk Cell Engagers, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd20+positive+human+nhl+cell+lines/cell+cell+engagers+nk+t/pm41412904-120-3-30
Average 86 stars, based on 1 article reviews
t cell nk cell engagers - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
mouse anti-human cd19-apch7  (Becton Dickinson)
90
Becton Dickinson mouse anti-human cd19-apch7
Table 2. Therapeutic antibodies in Phase 2/3 or Phase 3 clinical studies of cancer indications
Mouse Anti Human Cd19 Apch7, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd20+positive+human+nhl+cell+lines/hladr+antibody/pmc10885062-59-36-39
Average 90 stars, based on 1 article reviews
mouse anti-human cd19-apch7 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
rituximab  (Genentech inc)
90
Genentech inc rituximab
Table 2. Therapeutic antibodies in Phase 2/3 or Phase 3 clinical studies of cancer indications
Rituximab, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd20+positive+human+nhl+cell+lines/rituximab/us09068230-583-33-34
Average 90 stars, based on 1 article reviews
rituximab - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
131i-anti-b1 antibody  (Coulter Pharmaceutical Inc)
90
Coulter Pharmaceutical Inc 131i-anti-b1 antibody
Table 2. Therapeutic antibodies in Phase 2/3 or Phase 3 clinical studies of cancer indications
131i Anti B1 Antibody, supplied by Coulter Pharmaceutical Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd20+positive+human+nhl+cell+lines/131i+tositumomab++bexxar+/10__1592_slash_phco__20__4__337__34884-1204-8-10
Average 90 stars, based on 1 article reviews
131i-anti-b1 antibody - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
alemtuzumab (campath  (Schering-Plough corporation)
90
Schering-Plough corporation alemtuzumab (campath
Table 2. Therapeutic antibodies in Phase 2/3 or Phase 3 clinical studies of cancer indications
Alemtuzumab (Campath, supplied by Schering-Plough corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd20+positive+human+nhl+cell+lines/alemtuzumab+antibody/10__1309_slash_5cwp___u41a___fr1v___ym3f-36-27-34
Average 90 stars, based on 1 article reviews
alemtuzumab (campath - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Therapeutic and Immune Checkpoint Blocker Monoclonal Antibodies Approved for Cancer Treatment 5 , 10 , 53

Journal: Pharmacy and Therapeutics

Article Title: Cancer Immunotherapy, Part 2: Efficacy, Safety, and Other Clinical Considerations

doi:

Figure Lengend Snippet: Therapeutic and Immune Checkpoint Blocker Monoclonal Antibodies Approved for Cancer Treatment 5 , 10 , 53

Article Snippet: Rituxumab (Rituxan, Genentech) , 1997 , CD20 , Chimeric IgG1 , NHL; CLL.

Techniques: Bioprocessing

Table 2. Therapeutic antibodies in Phase 2/3 or Phase 3 clinical studies of cancer indications

Journal: mAbs

Article Title: Which are the antibodies to watch in 2013?

doi: 10.4161/mabs.22976

Figure Lengend Snippet: Table 2. Therapeutic antibodies in Phase 2/3 or Phase 3 clinical studies of cancer indications

Article Snippet: Genentech; Roche Pharma , Obinutuzumab , Humanized IgG1 , CD20 , Phase 3 , Diffuse large B cell lymphoma, CLL, NHL.

Techniques: